Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines

Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines

US Patent 6610301 · Granted Aug 26, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the normalization of immunological tests and kits for performing such2021
Method for the immunological diagnosis of a sample with a potential infection wi2021
Antigen-binding constructs that bind to and inhibit catalase and/or superoxide d2020
Device for serologically detecting Yersinia infections and/or secondary diseases2013
Peptides derived from capsid antigens of the Epstein-Barr virus and the use ther2009
Peptides derived from capsid antigens of the Epstein-Barr virus and the use ther2009
Method for determining early HCV seroconversion2006
Method for determining early HCV seroconversion2006
Immunologically active proteins from Borrelia burgdorferi2006
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which e2004
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which e2004
Immunologically active proteins from Borrelia burgdorferi2004